Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

Galectin-1, a novel ligand of neuropilin-1, activates VEGFR-2 signaling and modulates the migration of vascular endothelial cells

Abstract

Galectin-1 (Gal-1), a homodimeric prototype of the galectins with a single carbohydrate-recognition domain, was recently identified as being overexpressed in tumor-associated capillary endothelial cells. The role of Gal-1 in endothelial cellular functions and the mechanism of action of Gal-1 remain unknown. Neuropilin-1 (NRP1) is a neuronal receptor that mediates repulsive growth cone guidance, and NRP1 functions in endothelial cells as a coreceptor (with vascular endothelial growth factor receptors (VEGFRs)) for VEGF165. In this study, we found that Gal-1 was overexpressed in the tumor-associated endothelial cells of oral squamous cell carcinomas (P<0.001). Gal-1 increased the proliferation and adhesion of endothelial cells, and enhanced cell migration in combination with VEGF165. Surprisingly, Gal-1 selectively bound NRP1 via the carbohydrate-recognition domain, but did not bind VEGFR-1, VEGFR-2 or VEGFR-3. The Gal-1–NRP1 interaction mediated the migration and adhesion of endothelial cells. The binding of Gal-1 to NRP1 enhanced VEGFR-2 phosphorylation and stimulated the activation of the mitogen activated protein (MAP) kinases SAPK1/JNK (stress activated protein kinase-1/c-Jun NH2-terminal kinase). These findings show, for the first time, that Gal-1 can directly bind to NRP1 on endothelial cells, and can promote the NRP1/VEGFR-2-mediated signaling pathway as well as NRP1-mediated biological activities.

This is a preview of subscription content, access via your institution

Access options

Rent or buy this article

Prices vary by article type

from$1.95

to$39.95

Prices may be subject to local taxes which are calculated during checkout

Figure 1
Figure 2
Figure 3
Figure 4

Similar content being viewed by others

References

  • Camby I, Le Mercier M, Lefranc F, Kiss R . (2006). Galectin-1: a small protein with major functions. Glycobiology 16: 137R–157R.

    Article  CAS  Google Scholar 

  • Castro-Rivera E, Ran S, Thorpe P, Minna JD . (2004). Semaphorin 3B (SEMA3B) induces apoptosis in lung and breast cancer, whereas VEGF165 antagonizes this effect. Proc Natl Acad Sci USA 101: 11432–11437.

    Article  CAS  Google Scholar 

  • Chiang WF, Liu SY, Fang LY, Lin CN, Wu MH, Chen YC et al. (2007). Overexpression of galectin-1 at the tumor invasion front is associated with poor prognosis in early-stage oral squamous cell carcinoma. Oral Oncol (in press).

  • Clausse N, van den Brule F, Waltregny D, Garnier F, Castronovo V . (1999). Galectin-1 expression in prostate tumor-associated capillary endothelial cells is increased by prostate carcinoma cells and modulates heterotypic cell-cell adhesion. Angiogenesis 3: 317–325.

    Article  CAS  Google Scholar 

  • Elola MT, Chiesa ME, Alberti AF, Mordoh J, Fink NE . (2005). Galectin-1 receptors in different cell types. J Biomed Sci 12: 13–29.

    Article  CAS  Google Scholar 

  • Ferrara N, Gerber HP, LeCouter J . (2003). The biology of VEGF and its receptors. Nat Med 9: 669–676.

    Article  CAS  Google Scholar 

  • Fischer C, Sanchez-Ruderisch H, Welzel M, Wiedenmann B, Sakai T, André S et al. (2005). Galectin-1 interacts with the {alpha. J Biol Chem 280: 37266–37277.

    Article  CAS  Google Scholar 

  • Fons P, Herault JP, Delesque N, Tuyaret J, Bono F, Herbert JM . (2004). VEGF-R2 and neuropilin-1 are involved in VEGF-A-induced differentiation of human bone marrow progenitor cells. J Cell Physiol 200: 351–359.

    Article  CAS  Google Scholar 

  • Gaudet AD, Steeves JD, Tetzlaff W, Ramer MS . (2005). Expression and functions of galectin-1 in sensory and motoneurons. Curr Drug Targets 6: 419–425.

    Article  CAS  Google Scholar 

  • Glinsky VV, Huflejt ME, Glinsky GV, Deutscher SL, Quinn TP . (2000). Effects of Thomsen-Friedenreich antigen-specific peptide P-30 on beta- galactoside-mediated homotypic aggregation and adhesion to the endothelium of MDA-MB-435 human breast carcinoma cells. Cancer Res 60: 2584–2588.

    CAS  PubMed  Google Scholar 

  • Gu M, Wang W, Song WK, Cooper DN, Kaufman SJ . (1994). Selective modulation of the interaction of alpha 7 beta 1 integrin with fibronectin and laminin by L-14 lectin during skeletal muscle differentiation. J Cell Sci 107: 175–181.

    CAS  PubMed  Google Scholar 

  • He J, Baum LG . (2006). Endothelial cell expression of galectin-1 induced by prostate cancer cells inhibits T-cell transendothelial migration. Lab Invest 86: 578–590.

    Article  CAS  Google Scholar 

  • Hong TM, Chen YL, Wu YY, Yuan A, Chao YC, Chung YC et al. (2007). Targeting neuropilin 1 as an antitumor strategy in lung cancer. Clin Cancer Res 13: 4759–4768.

    Article  CAS  Google Scholar 

  • Hu B, Guo P, Bar-Joseph I, Imanishi Y, Jarzynka MJ, Bogler O et al. (2007). Neuropilin-1 promotes human glioma progression through potentiating the activity of the HGF/SF autocrine pathway. Oncogene 26: 5577–5586.

    Article  CAS  Google Scholar 

  • Jung EJ, Moon HG, Cho BI, Jeong CY, Joo YT, Lee YJ et al. (2007). Galectin-1 expression in cancer-associated stromal cells correlates tumor invasiveness and tumor progression in breast cancer. Int J Cancer 120: 2331–2338.

    Article  CAS  Google Scholar 

  • Kadri T, Lataillade JJ, Doucet C, Marie A, Ernou I, Bourin P et al. (2005). Proteomic study of Galectin-1 expression in human mesenchymal stem cells. Stem Cells Dev 14: 204–212.

    Article  CAS  Google Scholar 

  • Konigsberg W, Kirchhofer D, Riederer MA, Nemerson Y . (2001). The TF:VIIa complex: clinical significance, structure-function relationships and its role in signaling and metastasis. Thromb Haemost 86: 757–771.

    Article  CAS  Google Scholar 

  • Murga M, Fernandez-Capetillo O, Tosato G . (2005). Neuropilin-1 regulates attachment in human endothelial cells independently of vascular endothelial growth factor receptor-2. Blood 105: 1992–1999.

    Article  CAS  Google Scholar 

  • Neufeld G, Cohen T, Shraga N, Lange T, Kessler O, Herzog Y . (2002). The neuropilins: multifunctional semaphorin and VEGF receptors that modulate axon guidance and angiogenesis. Trends Cardiovasc Med 12: 13–19.

    Article  CAS  Google Scholar 

  • Ozeki Y, Matsui T, Yamamoto Y, Funahashi M, Hamako J, Titani K . (1995). Tissue fibronectin is an endogenous ligand for galectin-1. Glycobiology 5: 255–261.

    Article  CAS  Google Scholar 

  • Parsons-Wingerter P, Kasman IM, Norberg S, Magnussen A, Zanivan S, Rissone A et al. (2005). Uniform overexpression and rapid accessibility of alpha5beta1 integrin on blood vessels in tumors. Am J Pathol 167: 193–211.

    Article  CAS  Google Scholar 

  • Rabinovich GA . (2005). Galectin-1 as a potential cancer target. Br J Cancer 92: 1188–1192.

    Article  CAS  Google Scholar 

  • Rorive S, Belot N, Decaestecker C, Lefranc F, Gordower L, Micik S et al. (2001). Galectin-1 is highly expressed in human gliomas with relevance for modulation of invasion of tumor astrocytes into the brain parenchyma. Glia 33: 241–255.

    Article  CAS  Google Scholar 

  • Shintani Y, Takashima S, Asano Y, Kato H, Liao Y, Yamazaki S et al. (2006). Glycosaminoglycan modification of neuropilin-1 modulates VEGFR2 signaling. EMBO J 25: 3045–3055.

    Article  CAS  Google Scholar 

  • Thijssen VL, Postel R, Brandwijk RJ, Dings RP, Nesmelova I, Satijn S . (2006). Galectin-1 is essential in tumor angiogenesis and is a target for antiangiogenesis therapy. Proc Natl Acad Sci USA 103: 15975–15980.

    Article  CAS  Google Scholar 

  • Toscano MA, Bianco GA, Ilarregui JM, Croci DO, Correale J, Hernandez JD et al. (2007). Differential glycosylation of T(H)1, T(H)2 and T(H)-17 effector cells selectively regulates susceptibility to cell death. Nat Immunol 8: 825–834.

    Article  CAS  Google Scholar 

  • Vaisman N, Gospodarowicz D, Neufeld G . (1990). Characterization of the receptors for vascular endothelial growth factor. J Biol Chem 265: 19461–19466.

    CAS  PubMed  Google Scholar 

  • Valenzuela HF, Pace KE, Cabrera PV, White R, Porvari K, Kaija H et al. (2007). O-glycosylation regulates LNCaP prostate cancer cell susceptibility to apoptosis induced by galectin-1. Cancer Res 67: 6155–6162.

    Article  CAS  Google Scholar 

  • van den Brule FA, Waltregny D, Castronovo V . (2001). Increased expression of galectin-1 in carcinoma-associated stroma predicts poor outcome in prostate carcinoma patients. J Pathol 193: 80–87.

    Article  CAS  Google Scholar 

  • Zhou Q, Cummings RD . (1993). L-14 lectin recognition of laminin and its promotion of in vitro cell adhesion. Arch Biochem Biophys 300: 6–17.

    Article  CAS  Google Scholar 

Download references

Acknowledgements

This study was supported in part by grants NSC-96-2311-B-006-005-MY3 and NSC-95-2314-B-002-119-MY3 from the National Science Council, DOH-TD-B-111-004 from the Department of Health, CMFHR9405 and CMFHR9542 from the Chi-Mei Medical Center, by funds from a Taiwan Government program promoting academic excellence and the development of world-class research centers, and the Landmark Project of National Cheng Kung University, Taiwan.

Author information

Authors and Affiliations

Authors

Corresponding authors

Correspondence to T M Hong or Y L Chen.

Additional information

Supplementary Information accompanies the paper on the Oncogene website (http://www.nature.com/onc).

Supplementary information

Rights and permissions

Reprints and permissions

About this article

Cite this article

Hsieh, S., Ying, N., Wu, M. et al. Galectin-1, a novel ligand of neuropilin-1, activates VEGFR-2 signaling and modulates the migration of vascular endothelial cells. Oncogene 27, 3746–3753 (2008). https://doi.org/10.1038/sj.onc.1211029

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/sj.onc.1211029

Keywords

This article is cited by

Search

Quick links